Belite Bio, Inc. (BLTE)
164.50
+4.65
(+2.91%)
USD |
NASDAQ |
Jan 23, 16:00
164.50
0.00 (0.00%)
After-Hours: 20:00
Belite Bio Research and Development Expense (TTM): 38.01M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ocugen, Inc. | 35.49M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Ligand Pharmaceuticals, Inc. | 82.10M |
| IDEAYA Biosciences, Inc. | 368.29M |
| Terns Pharmaceuticals, Inc. | 76.99M |